5308032025-04-012025-06-305308032025-06-305308032025-04-012025-06-30in-capmkt:OtherExpenses1Member5308032025-04-012025-06-30in-capmkt:ReportableSegments1Member5308032025-04-012025-06-30in-capmkt:ReportableSegments2Member5308032025-04-012025-06-30in-capmkt:ReportableSegments3Member5308032025-04-012025-06-30in-capmkt:ReportableSegments4Member5308032025-04-012025-06-30in-capmkt:ReportableSegments1Member5308032025-04-012025-06-30in-capmkt:ReportableSegments2Member5308032025-04-012025-06-30in-capmkt:ReportableSegments3Member5308032025-04-012025-06-30in-capmkt:ReportableSegments4Member5308032025-04-012025-06-30in-capmkt:ReportableSegments1Member5308032025-06-30in-capmkt:ReportableSegments1Member5308032025-04-012025-06-30in-capmkt:ReportableSegments2Member5308032025-06-30in-capmkt:ReportableSegments2Member5308032025-04-012025-06-30in-capmkt:ReportableSegments3Member5308032025-06-30in-capmkt:ReportableSegments3Member5308032025-04-012025-06-30in-capmkt:ReportableSegments4Member5308032025-06-30in-capmkt:ReportableSegments4Member5308032025-04-012025-06-30in-capmkt:ReportableSegments1Member5308032025-06-30in-capmkt:ReportableSegments1Member5308032025-04-012025-06-30in-capmkt:ReportableSegments2Member5308032025-06-30in-capmkt:ReportableSegments2Member5308032025-04-012025-06-30in-capmkt:ReportableSegments3Member5308032025-06-30in-capmkt:ReportableSegments3Member5308032025-04-012025-06-30in-capmkt:ReportableSegments4Member5308032025-06-30in-capmkt:ReportableSegments4Member5308032025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15308032025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25308032025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss15308032025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares530803BHAGERIANAINE354C01027BHAGERIA INDUSTRIES LIMITEDMain BoardEquity2025-04-012026-03-312025-08-022025-07-25INRLakhsQuarterlyFirst quarterMulti segment2025-08-0210:00:002025-08-0211:30:00Declaration of unmodified opinionfalsefalseNA2025-04-012025-06-30UnauditedStandalone1580038000674710001647509000106446000072039000-99419000663460007140000775740002940660001482206000165303000016530300051236000-58370004539900001199040000000119904000-4100011986300021822100052.752.75002.752.75Notes on financial results :- <BR> 1 The Unaudited Standalone Financial Result for the quarter ended June 30 2025 have been reviewed by the Audit Committee and thereafter approved by the Board of Directors at the meeting held on August 02 2025. The Statutory Auditors of the Company have carried out Limited Review of the above results as per Regulatlon 33 of the SEBI Listing Obligation and Disclosure Requirements Regulations 2015. <BR> 2 The figures for the quarters ended on March 31 2025 are the balancing figures between audited figures for the full financial year and published year to date figures up to the third quarter of the respective financial year. <BR> 3 Corresponding figures of previous year quarter have been re-grouped re-arranged where considered necessary to correspond to current year quarter. <BR> 4 In accordance with Ind AS 108 Operating Segments, the Company has identified the following three reportable segments <BR> (a) Chemicals, which include Organic Chemicals and Inorganic Chemicals; (b) Solar Power, encompassing the Generation and Distribution of Solar Power and (c) Pharma and (d) Others, consisting of Trading and EPC in Solar. <BR> 5 The full financial results are also available on the stock exchanges website i.e. www.bseindia.com and www.nseindia.com and on the Company's website i.e. www.bhageriagroup.com. <BR> Other Expenses294066000Chemical1467773000Solar Power69838000Pharma17894000Other24533000158003800001580038000Chemical150794000Solar Power27356000Pharma-15182000Other-97610001532070007140000-19236000165303000Chemical4998736000Solar Power1269140000Pharma156222000Other20858600066326840005808490007213533000Chemical860330000Solar Power58893000Pharma92378000Other15485400011664550003557780001522233000Remeasurement of the defined benefit plans-370000Income tax effect on the above93000-2770000Exchange differences on translation of foreign operations2360002360000-41000UnauditedtrueSarada & Pareek LLPtrue2025-12-31